About SOMAÍ
compassionate care scientifically crafted
At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine.
SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that make us one of a few and the first European-based vertically integrated companies in the EU able to cater to the diverse needs of fast-growing global cannabis markets.
For patients
FOR HEALTHCARE PROFESSIONALs
For partners
Global Company News
The Rise of Multi-Country Operators: Somai Targets 20 Countries by Year End
Multi-state operators, or MSO’s, have long represented the biggest and most influential cannabis players in North America. Yet, as that…
Read more
The Shift Toward Recognised Brands in Medical Cannabis
For years, medical cannabis has been treated as a commodity, with little emphasis on brand differentiation. However, as the market…
Read more
Q4 2024: Global Medical Cannabis Continues To Soar
The global cannabis industry saw an incredible end to 2024. Q4 2024 showed that the international medical cannabis explosion is…
Read more
SOMAÍ Joins Forces with Dascoli to Advance Swiss Medical Cannabis Market
Expanding its global footprint, SOMAÍ continues its European growth with a Swiss market entry through a strategic partnership with Dascoli…
Read more
U.S.-style cannabis dispensaries are sweeping global medical markets
Medical cannabis markets around the world are starting to show signs of early United States and Canadian-style progressions. Consumer flower…
Read more
SOMAÍ Pharmaceuticals and PACCAN Join Forces to Transform Medicinal Cannabis in Asia and Beyond
SOMAÍ Pharmaceuticals partnered with Pacific Cannovation Company Limited (PACCAN) to transform Thailand into a global hub for high-quality medicinal cannabis…
Read more
SOMAÍ Pharmaceuticals Redefines Patients Experience with the Launch of Origins and Senses Lines
SOMAÍ Pharmaceuticals, a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company, proudly announces the global launch of its Origins and…
Read more
Portugal em Direto – Maior Empresa Da Europa Está Em Portugal
Portugal é o “epicentro do cultivo e produção de canábis”, revela CEO da SOMAÍ Pharmaceuticals
Com uma das maiores infraestruturas para cultivo e produção de canábis, Portugal é o maior exportador europeu desta planta para…
Read more
Cannabis industry predictions 2025: Market trends
Although new states continue to implement medical and adult-use cannabis programs, sales have been declining in the early adopters of…
Read more
The Grünhorn and Canymed Edge: Introducing Germany to SOMAÍ Extracts
Germany is one of the fastest-growing global medical cannabis markets. Recent changes in cannabis legislation have allowed doctors to more…
Read more
Business of Cannabis: Podcast | Releaf x SOMAÍ Pharmaceuticals
Releaf Clinic and SOMAÍ Pharmaceuticals have joined forces to provide UK patients with the largest portfolio of cannabis-based medicinal products…
Read more
2025 Czechia Cannabis Predictions from Cannafest
Czechia has a population of roughly 11 million people, and cannabis has been decriminalized since 2010. As one of the earliest…
Read more
Compounding the Issue: Germany's Medical Cannabis Market Needs a New Approach
Germany has some of the most progressive cannabis rules in the global markets. The cannabis industry is celebrating decriminalization, which provides…
Read more
Michael Sassano: Spain finally opens access to medical cannabis
After three years of political delays, Spain has taken a big step toward starting what it promised in terms of…
Read more
The Good, the Bad, and the Profitable: Inside Germany's EU-Leading Medical Cannabis Industry
The growth of the German medical cannabis market is poised to be highly profitable for the country. One billion euros…
Read more
The AusCannaPodcast S2 | E8 with Michael Sassano
In this episode of the AusCannaPodcast, Christina Mc Mullan sits down with Michael Sassano, CEO and Chairman of SOMAI Pharmaceuticals,…
Read more
Poland’s Path to Cannabis: Two Companies Meeting Market Demands
Poland is the fastest-growing new cannabis market in the entire global medical space. Not only is the extracts market growing…
Read more
SOMAÍ Pharmaceuticals e Universidade Lusófona colaboram em publicação científica sobre o efeito ‘entourage’
A indústria da canábis medicinal continua a evoluir, com a investigação a abrir caminho para aplicações terapêuticas inovadoras. A SOMAÍ Pharmaceuticals,…
Read more